fluoxetine has been researched along with Bulimia Nervosa in 18 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Bulimia Nervosa: An eating disorder that is characterized by a cycle of binge eating (BULIMIA or bingeing) followed by inappropriate acts (purging) to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In practice, in patients seeking treatment for bulimia nervosa, fluoxetine has been shown to provide only transient efficacy, and patients are exposed to the drug's adverse effects." | 7.73 | Fluoxetine. Bulimia nervosa: don't use. ( , 2006) |
| "This study compared the best available treatment for bulimia nervosa, cognitive-behavioural therapy (CBT) augmented by fluoxetine if indicated, with a stepped-care treatment approach in order to enhance treatment effectiveness." | 5.15 | Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial. ( Agras, S; Bryson, S; Crow, S; Fairburn, CG; Halmi, K; Kraemer, H; Mitchell, JE, 2011) |
| "Forty-five patients with bulimia nervosa were treated with the antidepressant fluoxetine and additionally with mood-stabilizers: 25 patients received carbamazepine and 20 patients - lamotrigine." | 5.14 | [Comparative effectiveness of mood stabilizers in the complex therapy of bulimia nervosa]. ( Marilov, VV; Sologub, MB, 2010) |
| " Antidepressants are commonly used to treat bulimia nervosa; high-dose fluoxetine is a standard approach, but many other antidepressants can be used." | 5.01 | Pharmacologic Treatment of Eating Disorders. ( Crow, SJ, 2019) |
| "Sertraline has been studied less extensively, and there have been a few studies concerning SSRIs that report follow-up data at more than 12 weeks of follow-up." | 2.73 | A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder. ( Brustolin, A; Campisi, S; Fassino, S; Lavagnino, L; Leombruni, P; Pierò, A, 2008) |
| "Fluoxetine for BN and lisdexamfetamine for BED are relatively safe and well-tolerated." | 2.58 | Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder. ( Bello, NT; Yeomans, BL, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Fornaro, M | 1 |
| Mondin, AM | 1 |
| Billeci, M | 1 |
| Fusco, A | 1 |
| De Prisco, M | 1 |
| Caiazza, C | 1 |
| Micanti, F | 1 |
| Calati, R | 1 |
| Carvalho, AF | 1 |
| de Bartolomeis, A | 1 |
| Yu, S | 1 |
| Zhang, Y | 1 |
| Shen, C | 1 |
| Shao, F | 1 |
| Gruber, M | 1 |
| Jahn, R | 1 |
| Stolba, K | 1 |
| Ossege, M | 1 |
| Himmerich, H | 1 |
| Treasure, J | 1 |
| Bello, NT | 1 |
| Yeomans, BL | 1 |
| Crow, SJ | 2 |
| Paszyńska, E | 1 |
| Słopień, A | 1 |
| Węglarz, M | 1 |
| Linden, RW | 1 |
| Leombruni, P | 1 |
| Pierò, A | 1 |
| Lavagnino, L | 1 |
| Brustolin, A | 1 |
| Campisi, S | 1 |
| Fassino, S | 1 |
| Downe, KA | 1 |
| Goldfein, JA | 1 |
| Devlin, MJ | 1 |
| Marilov, VV | 1 |
| Sologub, MB | 1 |
| Sysko, R | 1 |
| Sha, N | 1 |
| Wang, Y | 1 |
| Duan, N | 1 |
| Walsh, BT | 1 |
| Mitchell, JE | 2 |
| Agras, S | 1 |
| Crow, S | 1 |
| Halmi, K | 1 |
| Fairburn, CG | 2 |
| Bryson, S | 1 |
| Kraemer, H | 1 |
| Hay, PJ | 1 |
| Claudino, AM | 1 |
| Agras, WS | 1 |
| Halmi, KA | 1 |
| Nyman, JA | 1 |
| Molinari, E | 1 |
| Baruffi, M | 1 |
| Croci, M | 1 |
| Marchi, S | 1 |
| Petroni, ML | 1 |
| Rybakowski, F | 1 |
| Slopien, A | 1 |
| Komorowska, R | 1 |
| Antkowiak, R | 1 |
| Ciesielski, R | 1 |
| Rajewski, A | 1 |
| Grilo, CM | 1 |
| Masheb, RM | 1 |
| Wilson, GT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Stepped Care vs Best Available Care for Bulimia Nervosa[NCT00733525] | 293 participants (Actual) | Interventional | 2000-09-30 | Completed | |||
| Do Visuals of Symptom Change Increase Rates of Rapid Response in First Weeks of CBT for Eating Disorders?[NCT02940613] | 80 participants (Anticipated) | Interventional | 2016-12-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for fluoxetine and Bulimia Nervosa
| Article | Year |
|---|---|
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials.
Topics: Anorexia Nervosa; Antipsychotic Agents; Binge-Eating Disorder; Bulimia Nervosa; Feeding and Eating D | 2023 |
Efficacy of pharmacotherapies for bulimia nervosa: a systematic review and meta-analysis.
Topics: Bulimia; Bulimia Nervosa; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Vomiting | 2023 |
Psychopharmacological advances in eating disorders.
Topics: Animals; Anorexia Nervosa; Binge-Eating Disorder; Bulimia Nervosa; Drug Design; Fluoxetine; Humans; | 2018 |
Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder.
Topics: Binge-Eating Disorder; Bulimia Nervosa; Fluoxetine; Humans; Lisdexamfetamine Dimesylate; Medication | 2018 |
Pharmacologic Treatment of Eating Disorders.
Topics: Anorexia Nervosa; Antidepressive Agents, Second-Generation; Binge-Eating Disorder; Bulimia Nervosa; | 2019 |
Bulimia nervosa.
Topics: Administration, Oral; Bulimia; Bulimia Nervosa; Cognitive Behavioral Therapy; Evidence-Based Medicin | 2010 |
9 trials available for fluoxetine and Bulimia Nervosa
| Article | Year |
|---|---|
Parotid salivary parameters in bulimic patients - a controlled clinical trial.
Topics: Bulimia Nervosa; Female; Fluoxetine; Humans; Parotid Gland; Saliva; Salivary Glands; Secretory Rate; | 2015 |
A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
Topics: Adult; Body Mass Index; Bulimia Nervosa; Double-Blind Method; Female; Fluoxetine; Humans; Middle Age | 2008 |
Restraint, hunger, and disinhibition following treatment for binge-eating disorder.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Body Mass Index; Bulimia Nervosa; Cognitive B | 2009 |
[Comparative effectiveness of mood stabilizers in the complex therapy of bulimia nervosa].
Topics: Affect; Antidepressive Agents, Second-Generation; Antimanic Agents; Bulimia Nervosa; Carbamazepine; | 2010 |
Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia Nervosa; Clinical Protocols; Cognitive Beha | 2011 |
A cost effectiveness analysis of stepped care treatment for bulimia nervosa.
Topics: Adult; Bulimia Nervosa; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost-Benefit Analys | 2013 |
Binge eating disorder in obesity: comparison of different therapeutic strategies.
Topics: Adult; Aged; Body Mass Index; Bulimia Nervosa; Cognitive Behavioral Therapy; Cohort Studies; Combine | 2005 |
Temperament and character inventory and pharmacotherapeutic outcome in bulimia nervosa.
Topics: Adolescent; Adult; Assertiveness; Bulimia Nervosa; Buspirone; Female; Fluoxetine; Humans; Personalit | 2005 |
Rapid response to treatment for binge eating disorder.
Topics: Adolescent; Adult; Bulimia Nervosa; Cognitive Behavioral Therapy; Double-Blind Method; Female; Fluox | 2006 |
3 other studies available for fluoxetine and Bulimia Nervosa
| Article | Year |
|---|---|
['Barbie Doll Syndrome'. A case report of body dysmorphic disorder].
Topics: Adult; Beauty; Body Dysmorphic Disorders; Body Size; Bulimia Nervosa; Combined Modality Therapy; Dia | 2018 |
Early response to antidepressant treatment in bulimia nervosa.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bulimia Nervosa; Diagnostic and Statist | 2010 |
Fluoxetine. Bulimia nervosa: don't use.
Topics: Bulimia Nervosa; Clinical Trials as Topic; Contraindications; Cost-Benefit Analysis; Fluoxetine; Fra | 2006 |